BioIVT acquires Optivia Biotechnology

BioIVT, a provider of research models and services for drug development, has announced that it has acquired Santa Clara, CA-based Optivia Biotechnology and its...

Sanofi and Advent finalise negotiations for the acquisition of Zentiva

Sanofi and Advent International (Advent) have finished negotiations for the acquisition of Zentiva - Sanofi's European generics business. Advent and the companies have signed a Share Purchase Agreement worth €1.9 billion...

Takeda ups bid to $65 billion in negotiations to buy Shire

Takeda has increased offer to buy Shire for a mix of stock and cash worth ~$65 billion

Merck to sell Consumer Health to Procter & Gamble

Merck has sold its global Consumer Health business to Procter & Gamble

Advent in negotiations to acquire Sanofi’s generics business

Advent and Sanofi are in negotiations under which Advent would acquire Zentiva,

Certara acquires Analytica Laser

Certara announced it has acquired Analytica Laser which uses health economics and outcomes research (HEOR)

Mylan partners with Fujifilm Kyowa Kirin Biologics

Mylan partners with Fujifilm Kyowa Kirin Biologics to commercialise a biosimilar to Humira®

GSK buys out Novartis’ stake in Consumer Healthcare

GlaxoSmithKline plc have announced that it has reached an agreement with Novartis for the buyout of Novartis’ 36.5% stake in their Consumer Healthcare Joint...

Nanologica & Sterling partnership furthers new business venture

Nanologica AB has entered into a service agreement with global contract development and manufacturing organisation (CDMO) Sterling Pharma Solutions for the large-scale production of...

Evotec & Sanofi in talks to create open innovation R&D platform

Evotec and Sanofi enter into exclusive negotiations for Evotec to accelerate infectious disease research and development through a new open innovation platform in France In...

Latest articles

NHS trusts face worryingly high levels of senior vacancies

Why is high turnover among board-level roles make a negative impact on the performance of NHS trusts?

Triumph for Roche’s flu drug in phase III study

Roche has announced that the phase III CAPSTONE-2 study assessing the safety and efficacy of baloxavir marboxil in people at high risk of complications...

Leading Alzheimer’s Disease scientist joins NeuroCog Trials

Dr. Kathleen Anne Welsh-Bohmer, a specialist in Alzheimer’s Disease research, has joined the scientific leadership team at NeuroCog Trials (NCT) as the Vice President...